Lisa McKerracher of BioAxone BioSciences Joins Advisory Panel for Christopher Reeve Foundation

Lisa McKerracher, CEO of MBBP client BioAxone BioSciences, has accepted the role of Consortium Advisory Panelist for the Christopher & Dana Reeve Foundation. Dr. McKerracher will "direct the foundation's focus toward the identification, development, and translation of potential Spinal Cord Injury (SCI) therapies into the clinic." BioAxone BioSciences is a clinical-state biopharmaceutical company developing regenerative therapeutic …

Continue reading Lisa McKerracher of BioAxone BioSciences Joins Advisory Panel for Christopher Reeve Foundation